Drag a card by its title · ⚙ to size, swap or remove

The company

Palisade Bio, Inc.

PALI · Nasdaq

Health CareBiotechnologyNot moving yet

PALI stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 26.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 6
Industry in uptrend: 18% -12 in 4 wk
Insider buys, 12 months: $565K
Insider sales, 12 months: $841K
Officials’ trades on record: 0
Institutions holding: 121 (+29)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.

22 Apr – 21 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months10

Sale orders, 12 months4

Buyers · sellers2 · 2

Who	Did	Shares	Traded
Donald Allen WilliamsDirector	bought	10,000at $1.46	2 Oct 2026filed 5 Oct 2026
Donald Allen WilliamsDirector	bought	10,000at $1.42	1 Oct 2026filed 5 Oct 2026
Robert Baltera, Jr.Director	bought	25,000at $1.96	9 Jul 2026filed 10 Jul 2026
Robert Baltera, Jr.Director	bought	20,000at $1.99	8 Jul 2026filed 10 Jul 2026
John David FinleyCEO, CFO	sold	146,798at $2.07	7 Jul 2026filed 8 Jul 2026
Mitchell Lawrence JonesChief Medical Officer	sold	51,880at $2.05	7 Jul 2026filed 8 Jul 2026
Robert Baltera, Jr.Director	bought	30,000at $2.03	7 Jul 2026filed 8 Jul 2026
Robert Baltera, Jr.Director	bought	20,000at $2.05	6 Jul 2026filed 8 Jul 2026
Robert Baltera, Jr.Director	bought	10,000at $1.98	2 Jul 2026filed 6 Jul 2026
Robert Baltera, Jr.Director	bought	20,000at $1.98	1 Jul 2026filed 6 Jul 2026
John David FinleyCEO, CFO	sold	3,896at $1.75	12 Feb 2026filed 13 Feb 2026
Mitchell Lawrence JonesChief Medical Officer	sold	1,989at $1.75	12 Feb 2026filed 13 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders121+29 on the quarter

New · exited50 · 21

Reported value$362.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Soleus Capital Management, L.P.new · filed 11 Aug 2026	13,063,687$27.3M	+13,063,687
B Group, Inc.unchanged · filed 14 Aug 2026	11,414,285$23.9M	00.0%
AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026	11,081,434$23.2M	+2,370,049+27.2%
Jupiter Topco LLCnew · filed 14 Aug 2026	10,689,452$22.4M	+10,689,452
BlackRock, Inc.added · filed 7 Aug 2026	10,436,760$21.8M	+8,560,420+456.2%
Octagon Capital Advisors LPunchanged · filed 14 Aug 2026	10,276,317$21.5M	00.0%
PERCEPTIVE ADVISORS LLCreduced · filed 14 Aug 2026	8,425,065$17.6M	-503,084−5.6%
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	7,124,116$14.9M	00.0%
FRANKLIN RESOURCES INCunchanged · filed 13 Aug 2026	5,785,189$12.1M	00.0%
Point72 Asset Management, L.P.added · filed 14 Aug 2026	5,253,403$11.0M	+4,841,631+1175.8%